The BATTLE Trial: Personalizing Therapy for Lung Cancer

BACKGROUND: Lung cancer is the leading cancer cause of mortality worldwide; large-scale trials have failed to improve clinical outcomes of patients with chemorefractory non-small-cell lung cancer (NSCLC). METHODS: Following an initial equal randomization period, BATTLE adaptively randomized patients...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kim, Edward S., Herbst, Roy S., Wistuba, Ignacio I., Lee, J. Jack, Blumenschein, George R., Tsao, Anne, Stewart, David J., Hicks, Marshall E., Erasmus, Jeremy, Gupta, Sanjay, Alden, Christine M., Liu, Suyu, Tang, Ximing, Khuri, Fadlo R., Tran, Hai T., Johnson, Bruce E., Heymach, John V., Mao, Li, Fossella, Frank, Kies, Merrill, Papadimitrakopoulou, Vassiliki, Davis, Suzanne E., Lippman, Scott M., Hong, Waun K.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211116/
https://ncbi.nlm.nih.gov/pubmed/22586319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8274.CD-10-0010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares